Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled Trial
NCT ID: NCT05579158
Last Updated: 2024-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
337 participants
INTERVENTIONAL
2023-02-01
2024-01-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Time Restricted Feeding on Nonalcoholic Fatty Liver Disease
NCT03786523
The Effect of Time-restricted Eating on Liver Metabolism
NCT04997486
Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity
NCT04647149
Metabolic Impact of Time Restricted Feeding
NCT03129581
The Effect of Time-restricted Feeding on Physiological Function in Middle-aged and Older Adults
NCT02970188
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mobile application-supported both calorie restriction and time-restricted eating (mCR/TRE)
This arm receives wearable device and mobile application-supported nutritional counseling for four months. The nutritional counseling consists of both calorie restriction (500kcal below estimated energy requirement) and time-restricted eating (an 8-hour period (from 10 a.m. to 6 p.m.) each day).
Mobile application and wearable device
Mobile application-supported nutritional counseling includes education, monitoring, interaction, and physical activity
Time-restricted eating
Time-restricted eating (an 8-hour period (from 10 a.m. to 6 p.m.) each day)
Mobile application-supported calorie restriction (mCR)
This arm receives wearable device and mobile application-supported nutritional counseling for four months. The nutritional counseling consists of only calorie restriction (500kcal below estimated energy requirement).
Mobile application and wearable device
Mobile application-supported nutritional counseling includes education, monitoring, interaction, and physical activity
Calorie restriction (CR)
Standard of care. This arm receives a brief counseling of calorie restriction.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobile application and wearable device
Mobile application-supported nutritional counseling includes education, monitoring, interaction, and physical activity
Time-restricted eating
Time-restricted eating (an 8-hour period (from 10 a.m. to 6 p.m.) each day)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hepatic steatosis by imaging (ultrasound, computed tomography, magnetic resonance imaging, and controlled attenuation parameter (≥260 dB/m))
Exclusion Criteria
* Other causes of chronic liver disease (HBV, HCV), autoimmune diseases or chronic cholestatic liver disease
* Medications which cause liver disease or secondary hepatic steatosis (Tamoxifen, systemic corticosteroids, methotrexate, tetracycline, estrogens, valproic acid, and statin (registration is possible if statin is delivered in a consistent dosage within 12 weeks)
* Significant alcohol intake (\>210g/week for men, \>140g/week for women)
* Severe medical comorbidities (ischemic heart disease, 3rd degree atrioventricular block, chronic obstructive pulmonary disease, severe hypertension (blood pressure \> 200/120 mmHg)
* Psychiatric illnesses which limit ability to exercise safely
* Diagnosed with diabetes on medication or insulin
* Participation in a weight-loss program within 12 weeks
* MRI contraindications
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Health, Korea
OTHER_GOV
Hanyang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dae Won Jun
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dae Won Jun, M.D., Ph.D.
Role: STUDY_CHAIR
Hanyang University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hanyang University Seoul Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Oh JH, Yoon EL, Park H, Lee S, Jo AJ, Cho S, Kwon E, Nah EH, Lee JH, Park JH, Ahn SB, Jun DW. Efficacy and safety of time-restricted eating in metabolic dysfunction-associated steatotic liver disease. J Hepatol. 2025 Jun 19:S0168-8278(25)02272-X. doi: 10.1016/j.jhep.2025.06.005. Online ahead of print.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HanyangU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.